Revolution in sight
Branding and series A launch for a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Rebrand to usher in the next phase of the C4 Therapeutics story.
A clinical-stage debut for a precision player in the neuro space
THINKING OUTSIDE THE CHROMOSOME
New company name and brand identity support a vision fueled by optimism
A GENE THERAPY FIRST
Igniting global recognition of a landmark approval